Best GLP-1 Telehealth Providers 2026: Head-to-Head Comparison

Best GLP-1 Telehealth Providers 2026: Head-to-Head Comparison

April 2026 update: Compounded semaglutide is nearly gone. Most major telehealth providers have already exited compounding or are in the final stages of transitioning out. Branded oral semaglutide (Wegovy pill, $199–$299/mo) and the soon-to-be-approved oral GLP-1 pill orforglipron (PDUFA date: April 10, 2026, expected $149/mo) have significantly changed what "affordable" means. All pricing in this guide is verified from current provider profiles as of April 2026.

Choosing a GLP-1 telehealth provider is not a single question — it is three separate questions: How much do you want to pay each month? How much clinical oversight do you need? And how important is behavioral support to you? The right answer to each determines which provider belongs on your shortlist. Patients searching "cheapest GLP-1 online," "best GLP-1 telehealth provider 2026," or "compare GLP-1 programs without insurance" will find the answers to all three below.

This guide covers the six providers that account for the overwhelming majority of GLP-1 telehealth volume: Ro, Hims & Hers, Found, Noom, WeightWatchers Clinic, and Calibrate. We compare them on price, medications, clinical model, and support — and tell you plainly who each one is actually best for.

---

How do the top six GLP-1 telehealth providers compare at a glance?

Ro and Hims start at ~$199/month for oral Wegovy with no separate membership fee. WeightWatchers Clinic adds orforglipron at ~$198/month total pending FDA approval. Calibrate and Found cost more but include video consultations with obesity medicine specialists. Calibrate is the only one with labs included.

Provider	Starting price (Mar 2026)	Consultation type	Coaching	Labs	Insurance navigation
Ro	$199/mo (oral Wegovy)	Async only	Metabolic coaching included	No	PA support available
Hims & Hers	~$199/mo (oral Wegovy 4mg)	Async only	No	No	PA support (semaglutide only)
Found	$399/mo cash-pay; varies w/ insurance	Video (obesity medicine)	Included	No	Yes
Noom	$149/mo medication + program fee	Video required	CBT curriculum + coach	No	Yes
WeightWatchers Clinic	$49/mo membership + medication	Video	WW behavioral program	No	Yes
Calibrate	$199/mo program + ~$25/mo medication (insured)	Video (obesity medicine)	1:1 coaching included	Included	Full PA + appeals

Note on orforglipron: The FDA is expected to decide on orforglipron — a daily oral GLP-1 pill — by April 10, 2026. If approved, it is expected to be available at $149/mo through most providers. This would significantly shift the pricing landscape for cash-pay patients at every provider on this list.

---

Which GLP-1 telehealth provider is best for your situation?

The right provider depends on three variables: budget, how much clinical oversight you want, and whether you have insurance. Ro wins on price-to-value for cash-pay patients. Calibrate wins on clinical depth for insured patients. The matrix below maps each situation to the best choice.

Use this to narrow your choice before reading the full mini-reviews.

If you want…	Best choice
Lowest cash-pay price with coaching included	Ro (oral Wegovy $199/mo, metabolic coaching no extra charge)
Brand-only semaglutide from a large public company	Hims & Hers (no compounding, Novo Nordisk partnership)
Video consultations + obesity medicine specialist without full program cost	Found
Behavioral support baked into the program	Noom (CBT curriculum) or WeightWatchers Clinic (Points + community)
Most clinical depth, labs included	Calibrate
Insurance coverage for brand-name GLP-1	Calibrate or Found (both support prior authorization)
Avoiding injections entirely	Ro or Hims (oral Wegovy pill available now; orforglipron pending)
Long-term weight maintenance support	Noom (behavioral focus) or Calibrate (year-long program)

---

What are the detailed reviews for each GLP-1 telehealth provider?

Each provider below has a distinct positioning: Ro for transparent cash-pay pricing, Hims for brand-name semaglutide from a large public company, Found for specialist care without long-term commitment, Noom for behavioral therapy plus medication, WeightWatchers Clinic for an integrated behavioral community, and Calibrate for maximum clinical depth with labs included.

Ro

Price: Oral Wegovy $199–$299/mo (cash-pay) | Compounded semaglutide $149/mo (transitioning out) | Zepbound $299/mo via LillyDirect

Ro is in the middle of a transition that tells you a lot about where telehealth is heading. The platform built its weight loss business on compounded semaglutide at $149/month — and now, ahead of the FDA's enforcement deadline, it has built out a full branded lineup: oral Wegovy ($199–$299/mo), Zepbound ($299/mo), and injectable Wegovy through insurance. Compounded semaglutide is still technically available through Ro, but the platform is actively steering new patients toward branded options. Starting on compounded semaglutide in April 2026 carries real supply and regulatory risk.

Ro includes metabolic health coaching at no extra charge — uncommon among async-only providers at this price. Most competitors strip everything down to medication delivery and messaging. The clinical model is still basic (no video visits, no lab testing, no dietitian), but the coaching inclusion bridges part of that gap. Once orforglipron receives FDA approval, Ro is expected to add it at approximately $149/mo — a price point that would make their no-subscription-fee model the most cost-competitive path to a branded oral GLP-1.

Bottom line: Ro is the strongest choice for patients who want an established, large-platform branded GLP-1 experience at transparent cash-pay pricing. The pending orforglipron launch could make it the clear value leader for budget-conscious patients.

Read the full Ro provider profile →

---

Hims & Hers

Price: Oral Wegovy 4mg ~$199/mo | Oral Wegovy 9–25mg ~$299/mo | Brand injectable Wegovy: insurance-dependent

Hims & Hers (NYSE: HIMS) exited compounding entirely in 2026 and became a brand-only Novo Nordisk partner. The clearest value proposition is now for patients with insurance coverage for Wegovy or who specifically want oral Wegovy from a large, publicly traded company with SEC oversight — not the cash-pay compounded semaglutide audience the platform previously served.

The Hers brand (women's health sister platform) runs an identical GLP-1 program — same medications, same pricing, same async consultation model. The difference is branding and surrounding content: Hers wraps the program in women's health context, with education on hormonal weight gain, postpartum weight, and menopause-related metabolic changes. For weight loss specifically, choosing between Hims and Hers comes down to which interface resonates more — the clinical programs are the same.

Neither platform offers tirzepatide (Zepbound) as a cash-pay option, lab testing, or coaching. For patients who want clinical depth, behavioral support, or a medication menu beyond semaglutide, other providers on this list serve you better. But for brand-name oral Wegovy from a large, trusted platform with prior authorization support through a direct Novo partnership, Hims is a legitimate top choice.

Bottom line: Hims & Hers works best for insured patients who want brand Wegovy (injectable or oral) through a large, accountable platform. Cash-pay patients who prioritize value should compare carefully against Ro and, once approved, orforglipron-based pricing elsewhere.

Read the full Hims provider profile → | Read the full Hers provider profile →

---

Found

Price: Brand injectable GLP-1 cash-pay: $399/mo (full program included) | Brand-name injectable via insurance: varies + program fee

Found occupies the middle ground between bare-bones medication delivery and premium year-long programs — and it holds that position with real differentiation. The platform pairs video consultations with board-certified obesity medicine specialists (not general practitioners) with coaching and community support. Most competitors at a similar price point use async-only models; Found's video consultation requirement means a clinician has actually evaluated you, not just reviewed your questionnaire.

The transition away from compounded semaglutide is complete at Found. The platform now operates entirely on branded GLP-1 options — injectable Wegovy and Zepbound through insurance, with cash-pay injectable at $399/mo for the full program. Orforglipron, once FDA-approved (PDUFA April 10, 2026), is expected to become Found's primary budget pathway. The behavior change focus is genuine — Found was built around the premise that GLP-1 discontinuation leads to weight regain without behavioral scaffolding, and the coaching component reflects that. Shipping runs 5–7 days, slower than most competitors, which is a real friction point for patients eager to start.

Bottom line: Found is the right pick for patients who want obesity medicine specialists and behavioral support without the cost or commitment of Calibrate. It is not the cheapest option, but it delivers more clinical credibility than the async-only platforms.

Read the full Found provider profile →

---

Noom

Price: Medication billed separately (pending orforglipron ~$149/mo + program fee) | Oral Wegovy $199–$299/mo + program fee | Video consultation required

Noom's pitch is the most distinctive on this list: a decade-old cognitive behavioral therapy (CBT) curriculum combined with GLP-1 medication. The daily behavioral lessons, personal coaching, and group sessions are not a marketing add-on — they predate Noom Med by over a decade. For patients who are concerned about weight regain after stopping GLP-1 medication (a documented and common outcome), the behavioral component may deliver genuine long-term value that pure medication-delivery platforms cannot.

Noom Med launched in 2023, and the combined GLP-1 + CBT program has limited published clinical data. You cannot opt out of the coaching component to lower costs — the behavioral curriculum is mandatory regardless of whether you find it valuable. Branded medication pricing on the higher end adds to total cost for patients without insurance. The video consultation requirement is actually a positive from a clinical rigor standpoint, but it adds friction compared to same-day async approvals at Ro or Hims.

Bottom line: Noom is the strongest choice for patients who believe behavioral change is the missing piece in their weight loss history. If you've tried medication-only approaches and struggled with adherence or post-treatment regain, Noom's structure is worth the premium. If you just want affordable medication access with minimum overhead, simpler platforms are cleaner.

Read the full Noom provider profile →

---

WeightWatchers Clinic

Price: $49/mo clinic membership + medication (orforglipron ~$149/mo pending; brand injectable via insurance) | All-in estimate pending orforglipron approval: ~$198/mo

WeightWatchers Clinic is the result of WW's $132 million acquisition of Sequence in 2023 — a deal that gave a 60-year behavioral weight loss brand direct access to GLP-1 prescribing infrastructure. The integration is what distinguishes it: a GLP-1 prescription alongside the WeightWatchers behavioral program (Points system, workshops, app-based coaching) and a community infrastructure that predates every telehealth startup on this list.

The layered pricing is the main friction point. The $49/mo clinic membership is separate from the medication cost and separate from a full WeightWatchers behavioral program membership — patients who want the complete integrated experience pay more than the headline number suggests. Provider quality has also been reported as inconsistent across states, which is expected from a clinical division that is only three years old. The 2024 corporate layoffs (roughly 40% of staff) raised questions about operational stability that the company has not fully answered. Compounded GLP-1 medications are no longer offered; the platform now runs entirely on branded options plus, once approved, orforglipron at $149/mo.

Bottom line: WeightWatchers Clinic is the right choice for patients who want medication alongside a structured behavioral program with community infrastructure. If you've tried GLP-1s without sustainable results and think the behavioral framework is what you're missing, WW's decades of iteration on that problem is a real asset. Just price out the full bundle before committing.

Read the full WeightWatchers Clinic provider profile →

---

Calibrate

Price: $199/mo program fee (initial 3-month commitment: $597) + medication | With insurance: ~$25/mo medication copay | Without insurance: $199 + ~$149/mo pending orforglipron = ~$348/mo

Calibrate is the most clinically comprehensive GLP-1 telehealth program available. Video visits with board-certified obesity medicine physicians, metabolic lab panels included in the program fee, and 1:1 coaching across food, sleep, exercise, and emotional health. The year-long program is explicitly designed as a metabolic reset — the medication is one component in a structured intervention, not the product itself. Their insurance navigation is a genuine differentiator: most commercial insurance members end up paying around $25/mo for branded Wegovy or Zepbound after Calibrate's prior authorization and appeals support.

The commitment requirements reflect the clinical ambition. A three-month initial payment ($597), then month-to-month at $199, is a significant ask before you know whether the program works for you. The one-year program framing also means this is a structured commitment, not a subscription you can cancel without thought. Calibrate does not offer compounded medication, which removes one risk but limits options for patients seeking the lowest cash-pay entry point. If orforglipron receives FDA approval in April, cash-pay patients on Calibrate would be looking at roughly $348/month total — expensive compared to standalone orforglipron at $149/month, but inclusive of labs, specialist visits, and coaching that other providers charge separately or do not offer at all.

Bottom line: Calibrate makes the most sense for patients with insurance that covers GLP-1 medications (reducing total cost substantially), patients with complex metabolic needs who benefit from specialist oversight and lab monitoring, or patients for whom previous attempts with simpler programs failed. It is the wrong choice for cost-sensitive patients without good insurance.

Read the full Calibrate provider profile →

---

What will you actually pay at each GLP-1 telehealth provider?

For cash-pay patients, Ro and Hims start at $199/month for oral Wegovy. Once orforglipron is approved (~April 10, 2026), most providers are expected to offer it at $149/month — which would make WeightWatchers Clinic's total ~$198/month and become the cheapest branded GLP-1 path. For insured patients, Calibrate's $224/month total (program + copay) is the most competitive all-inclusive option.

The cheapest option depends on whether you have insurance and which medication you're on.

For cash-pay patients without insurance (April 2026):

Provider	Estimated monthly cost	What's included
Ro (oral Wegovy 4mg)	$199/mo	Medication, async consultation, metabolic coaching
Hims (oral Wegovy 4mg)	~$199/mo	Medication, async consultation
WeightWatchers Clinic + orforglipron*	~$198/mo	Membership + medication (*orforglipron pending FDA approval April 10)
Noom + orforglipron*	$149/mo medication + program fee	Medication, video consultation, CBT coaching (*pending)
Found (brand injectable)	$399/mo	Medication, video specialist consultation, coaching, community
Calibrate (orforglipron*)	~$348/mo	Program + medication (*pending FDA approval)

For patients with insurance covering brand-name GLP-1s:

Calibrate, Found, Sequence, and WeightWatchers Clinic all provide prior authorization support. If your insurance covers Wegovy or Zepbound, Calibrate's economics ($199/mo program + ~$25/mo copay = ~$224/mo total for a comprehensive clinical program) become substantially more competitive.

Approaching the April 10 orforglipron decision:

Orforglipron — an oral daily pill producing approximately 10–12% body weight loss — is 13 days from its PDUFA date at time of writing. If approved, it is expected to be available at ~$149/mo through most providers. That would reset the cash-pay minimum to $149/mo at Ro, Noom, and WeightWatchers Clinic. Factor this into any decision you are making in the next two weeks.

---

FAQ

What is the cheapest GLP-1 telehealth option in April 2026?

At current pricing, oral Wegovy through Ro or Hims starts at ~$199/mo cash-pay — no separate membership fee required. Orforglipron (FDA decision expected April 10, 2026) is anticipated at $149/mo through most major providers. Compounded semaglutide at $149/mo is still technically available through some platforms, but supply is declining under active FDA enforcement pressure and is not recommended for patients starting new treatment in April 2026.

How is Ro different from Hims for GLP-1 treatment?

Both offer oral Wegovy at similar pricing (~$199/mo for lower doses) and use async-only consultation models. Key differences: Ro includes metabolic health coaching at no extra charge; Hims does not. Hims exited compounding entirely and is semaglutide-only (no tirzepatide); Ro offers Zepbound ($299/mo) and had compounded semaglutide as a transitional option. Hims is a publicly traded company (NYSE: HIMS), which some patients see as a trust signal. For most cash-pay patients, Ro offers slightly more value per dollar at the same price point.

Does WeightWatchers Clinic offer the same GLP-1 medications as other providers?

WeightWatchers Clinic offers brand-name Ozempic/Wegovy (semaglutide), Wegovy HD (7.2mg), Mounjaro/Zepbound (tirzepatide), and non-GLP-1 adjuncts including metformin, topiramate, and bupropion/naltrexone (Contrave) — a broader medication menu than most telehealth-only platforms. Orforglipron is expected to be added at approximately $149/mo pending FDA approval (April 10, 2026). Compounded GLP-1 medications are no longer offered.

What is the difference between Found and Calibrate?

Both use video consultations with board-certified obesity medicine specialists and combine GLP-1 prescriptions with behavioral support. The main differences: Calibrate includes lab testing in the program fee; Found does not. Calibrate requires a one-year program commitment and a $199/mo program fee; Found does not lock you into a year-long contract. For insured patients with good coverage for brand GLP-1s, Calibrate's economics can be competitive. For patients who want specialist-level care without a year-long commitment, Found is the cleaner choice. See our full Found vs Calibrate comparison for a detailed breakdown.

Does Noom actually work for GLP-1 weight loss?

Noom Med (GLP-1 prescriptions) launched in 2023. The medications themselves — brand-name semaglutide and tirzepatide — have a well-documented clinical efficacy record. What lacks published data is the specific combination of Noom's CBT curriculum with GLP-1 medication. Noom has not published clinical trial data demonstrating that their combined program outperforms medication alone. What is plausible — and supported by weight management research broadly — is that behavioral scaffolding reduces weight regain after medication discontinuation. The theory is sound; the Noom-specific evidence is not yet there.

Which GLP-1 telehealth provider is best for patients with insurance?

Calibrate and Found both run aggressive prior authorization and insurance navigation programs. Calibrate in particular reports that most commercial insurance members end up paying approximately $25/mo for brand-name Wegovy or Zepbound after PA support — making the $199/mo program fee + ~$25/mo copay a more competitive total than it first appears. WeightWatchers Clinic and Hims also provide prior authorization support. If insurance coverage is your primary variable, Calibrate's insurance navigation infrastructure is the most developed on this list.

Can I get GLP-1 medication without a subscription fee?

Yes. Ro and Hims both include consultation access in the medication price — there is no separate subscription or membership fee. At Ro, oral Wegovy starts at $199/mo all-in. WeightWatchers Clinic charges a $49/mo clinic membership in addition to medication. Found, Calibrate, Noom, and Sequence all have program fees separate from medication costs.

---

How does Telehealth Ally evaluate GLP-1 providers?

Telehealth Ally evaluates providers on price transparency, clinical protocols (prescriber credentials, titration approach, lab requirements), patient outcomes, access, support quality, and value. No provider pays for placement or ranking in this guide. All pricing is verified from current provider profiles and updated when changes are confirmed. Our full editorial methodology is published here.

---

Pricing and availability current as of March 28, 2026. Orforglipron pricing is anticipated based on Eli Lilly announcements and is subject to change following FDA action. Compounded semaglutide availability is subject to ongoing FDA enforcement activity. Telehealth Ally is not affiliated with any provider listed in this guide.